Genzyme Corp. Genzyme Corporation operates as a biotechnology company worldwide. It focuses on rare genetic disease disorders‚ renal diseases‚ orthopedics‚ cancers‚ transplant and immune diseases‚ and diagnostic and predictive testing areas. Its leading drugs are Cerezyme‚ Fabrazyme‚ Myozyme‚ Aldurazyme‚ Elaprase‚ Renagel and Renvela‚ and many others. It has about 7‚000 employees. The current Chairman‚ President‚ & CEO is Henri A. Termeer. The company was founded in 1981 and is based in Cambridge
Premium Biogen Idec Biotechnology
Executive Summary Biogen is a global biotechnology company headquartered in Cambridge‚ Massachusetts. Biogen is engaged in the research and development of biopharmaceuticals for human health care. Its main product is Avonex‚ a drug for the treatment of Multiple Sclerosis. Eighty-two percent of its revenues in 2000 came from the sale of this sole product. Biogen is also involved in the research of drugs for psoriasis‚ Crohn ’s disease‚ congestive heart failure‚ and cancer. Biogen believes that its
Premium Pharmaceutical industry Drug discovery Biotechnology
Business Basics Biogen Idec Biogen Idec is a global biotechnology company focused on discovering‚ developing‚ manufacturing and marketing therapies for the treatment of multiple sclerosis and other autoimmune disorders‚ neurodegenerative diseases and haemophilia. Biogen Idec was formed in 2003 from the merger of two companies‚ Biogen Inc.‚ founded in 1978‚ and IDEC Pharmaceuticals Corporation‚ founded in 1985. It is one of the largest biotechnology companies in the world. Biogen Idec covers the
Premium Financial ratio Biogen Idec Financial ratios
Table of contents Contents | Pages | 1.0 introduction | 2-3 | 2.0 overview of NHS Shetland | 3 | 2.1 NHS performance system | 4 | 3.0 overview of Biogen Idec Inc. | 5 | 3.1 Biogen Idec Inc. performance management system | 6 | 4.0 comparisons between NHS and Biogen performance system | 7 | 4.1 Weakness of both Performance management systems | 8-9 | 4.2 General summary of both performance approaches | 10 | 5.0 conclusion | 11 | 6.0 references | 12-13 | 7.0 appendixes
Premium Performance management Biogen Idec Management
performance [online]. Available from: http://www.opm.gov/perform/articles/pdf3.asp. [Accessed 31 December 2009]. * Taylor‚ S * Torrington‚ D.‚ Hall‚ L. and Taylor‚ S. (2005) Human resource management. 6th ed. Harlow: FT Prentice Hall. IDS HR Studies (2005) Biogen Idec — IDS HR Studies 796 [online]. Available from: http://www.idshrstudies.com/app/smg/gbn/frameless/document/body?docguid=Iad5e68c13c2e11dc854300123f934565&restype=31
Premium Human resource management Performance management Performance appraisal
Stock Holdings Why we kept these stocks; Focus on FUTURE & what was created or expanded. Compay changes in management or business structure. Etc. Microsoft Many high profile insider investments lead me to believe in the company. Mr. Morfit‚ General Director of Microsoft‚ is stepping up to the plate again and buying more shares on a recent pullback. This leads us to believe he is very pleased with the new CEO and sees big things in the future for this ‘mature tech’ stock. We’re overall very comfortable
Premium Revenue Biogen Idec Stock market
The band gap value of the DBAP molecule was calculated as 5.60 eV‚ which indicates that the DBAP molecule has stable molecular structure and the value is comparable with the band gap energy value of the reported bio-active molecules [16]. The higher hardness and lower softness value indicates the stability of the DBAP molecule. The obtained lower chemical potential and electrophilicity index values are comparable with the potential bioactive molecules [14‚ 16]. DOS spectrum was also simulated by
Premium Chemistry Oxygen Acid
rganizational tataA) What elements of the different motivation theories (Herzberg‚ Maslow‚ etc) might be relevant in this change process? Some of the changes that occurred at Biogen included a change of location‚ change in management and change in the distribution of roles of departments. Those who were most affected by these changes are the employees; because of the transition to a different country they had to make a tough decision‚ whether to move and keep their jobs or stay and quit. Herzberg
Premium Motivation Maslow's hierarchy of needs
blood-coagulating medication that Biogen had been creating as a more viable option to heparin‚ the opposition to thickening medication most broadly utilized as a part of the intense treatment of coronary heart disease. Upon looking into Biogen’s clinical test outcomes‚ on the other hand‚ Meanwell had believed that a business still existed for the medication. In this way‚ in March 1997‚ the Medicines Company procured all rights to Angiomax and set out to finish the clinical trials that Biogen had started upon securing
Premium Pharmacology Pharmaceutical drug Drug
76 CHAPTER 7 CURRENCY FUTURES AND OPTIONS MARKETS This chapter describes foreign currency futures and options contracts and shows how they can be used to manage foreign exchange risk or take speculative positions on currency movements. It also shows how to read the prices of these contracts as they appear in the financial press. SUGGESTED ANSWERS TO CHAPTER 7 QUESTIONS 1. On April 1‚ the spot price of the British pound was $1.86 and the price of the June futures contract was $1.85. During
Premium Futures contract Call option Option